カテゴリー： QYResearch, 世界

神経内分泌腫瘍治療の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Neuroendocrine Tumor Treatment Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18748）・商品コード：DATA909X18748
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：99
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、神経内分泌腫瘍治療の世界市場について調査・分析し、神経内分泌腫瘍治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（エベロリムス、スニチニブ、ルタタテート、ランレオチド、オクトレオチド）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の神経内分泌腫瘍治療市場動向
・主要企業別マーケットシェア
・神経内分泌腫瘍治療の種類別市場規模2014-2019
（エベロリムス、スニチニブ、ルタタテート、ランレオチド、オクトレオチド）
・神経内分泌腫瘍治療の用途別市場規模2014-2019
（病院、クリニック、その他）
・神経内分泌腫瘍治療の北米市場：主要企業・種類別/用途別市場規模
・神経内分泌腫瘍治療のヨーロッパ市場：主要企業・種類別/用途別市場規模
・神経内分泌腫瘍治療の中国市場：主要企業・種類別/用途別市場規模
・神経内分泌腫瘍治療の日本国内市場：主要企業・種類別/用途別市場規模
・神経内分泌腫瘍治療の東南アジア市場：主要企業・種類別/用途別市場規模
・神経内分泌腫瘍治療のインド市場：主要企業・種類別/用途別市場規模
・神経内分泌腫瘍治療の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Exelixis, Inc.、Advanced Accelerator Applications、Dauntless Pharmaceuticals, Inc.、Hutchinson Medipharma Limited、Ispen、Novartis AG、Progenics Pharmaceuticals, Inc.、Tarveda Therapeutics）
・神経内分泌腫瘍治療の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

Neuroendocrine tumors (NETs) are neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. Many are benign, while some are malignant. They most commonly occur in the intestine, where they are often called carcinoid tumors, but they are also found in the pancreas, lung and the rest of the body.In 2018, the global Neuroendocrine Tumor Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Neuroendocrine Tumor Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neuroendocrine Tumor Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Exelixis, Inc.
Advanced Accelerator Applications
Dauntless Pharmaceuticals, Inc.
Hutchinson Medipharma Limited
Ispen
Novartis AG
Progenics Pharmaceuticals, Inc.
Tarveda Therapeutics

Market segment by Type, the product can be split into
Everolimus
Sunitinib
Lu-Dotatate
Lanreotide
Octreotide

Market segment by Application, split into
Hospitals
Clinic
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Neuroendocrine Tumor Treatment status, future forecast, growth opportunity, key market and key players.
To present the Neuroendocrine Tumor Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Neuroendocrine Tumor Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Neuroendocrine Tumor Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Everolimus
1.4.3 Sunitinib
1.4.4 Lu-Dotatate
1.4.5 Lanreotide
1.4.6 Octreotide
1.5 Market by Application
1.5.1 Global Neuroendocrine Tumor Treatment Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Neuroendocrine Tumor Treatment Market Size
2.2 Neuroendocrine Tumor Treatment Growth Trends by Regions
2.2.1 Neuroendocrine Tumor Treatment Market Size by Regions (2019-2025)
2.2.2 Neuroendocrine Tumor Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Neuroendocrine Tumor Treatment Market Size by by Players
3.1.1 Global Neuroendocrine Tumor Treatment Revenue by by Players (2014-2019)
3.1.2 Global Neuroendocrine Tumor Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Neuroendocrine Tumor Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Neuroendocrine Tumor Treatment Key Players Head office and Area Served
3.3 Key Players Neuroendocrine Tumor Treatment Product/Solution/Service
3.4 Date of Enter into Neuroendocrine Tumor Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Neuroendocrine Tumor Treatment Market Size by Type (2014-2019)
4.2 Global Neuroendocrine Tumor Treatment Market Size by Application (2014-2019)

5 North America
5.1 North America Neuroendocrine Tumor Treatment Market Size (2014-2019)
5.2 Neuroendocrine Tumor Treatment Key Players in North America
5.3 North America Neuroendocrine Tumor Treatment Market Size by Type
5.4 North America Neuroendocrine Tumor Treatment Market Size by Application

6 Europe
6.1 Europe Neuroendocrine Tumor Treatment Market Size (2014-2019)
6.2 Neuroendocrine Tumor Treatment Key Players in Europe
6.3 Europe Neuroendocrine Tumor Treatment Market Size by Type
6.4 Europe Neuroendocrine Tumor Treatment Market Size by Application

7 China
7.1 China Neuroendocrine Tumor Treatment Market Size (2014-2019)
7.2 Neuroendocrine Tumor Treatment Key Players in China
7.3 China Neuroendocrine Tumor Treatment Market Size by Type
7.4 China Neuroendocrine Tumor Treatment Market Size by Application

8 Japan
8.1 Japan Neuroendocrine Tumor Treatment Market Size (2014-2019)
8.2 Neuroendocrine Tumor Treatment Key Players in Japan
8.3 Japan Neuroendocrine Tumor Treatment Market Size by Type
8.4 Japan Neuroendocrine Tumor Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Neuroendocrine Tumor Treatment Market Size (2014-2019)
9.2 Neuroendocrine Tumor Treatment Key Players in Southeast Asia
9.3 Southeast Asia Neuroendocrine Tumor Treatment Market Size by Type
9.4 Southeast Asia Neuroendocrine Tumor Treatment Market Size by Application

10 India
10.1 India Neuroendocrine Tumor Treatment Market Size (2014-2019)
10.2 Neuroendocrine Tumor Treatment Key Players in India
10.3 India Neuroendocrine Tumor Treatment Market Size by Type
10.4 India Neuroendocrine Tumor Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Neuroendocrine Tumor Treatment Market Size (2014-2019)
11.2 Neuroendocrine Tumor Treatment Key Players in Central & South America
11.3 Central & South America Neuroendocrine Tumor Treatment Market Size by Type
11.4 Central & South America Neuroendocrine Tumor Treatment Market Size by Application

12 International Players Profiles
12.1 Exelixis, Inc.
12.1.1 Exelixis, Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Neuroendocrine Tumor Treatment Introduction
12.1.4 Exelixis, Inc. Revenue in Neuroendocrine Tumor Treatment Business (2014-2019))
12.1.5 Exelixis, Inc. Recent Development
12.2 Advanced Accelerator Applications
12.2.1 Advanced Accelerator Applications Company Details
12.2.2 Company Description and Business Overview
12.2.3 Neuroendocrine Tumor Treatment Introduction
12.2.4 Advanced Accelerator Applications Revenue in Neuroendocrine Tumor Treatment Business (2014-2019)
12.2.5 Advanced Accelerator Applications Recent Development
12.3 Dauntless Pharmaceuticals, Inc.
12.3.1 Dauntless Pharmaceuticals, Inc. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Neuroendocrine Tumor Treatment Introduction
12.3.4 Dauntless Pharmaceuticals, Inc. Revenue in Neuroendocrine Tumor Treatment Business (2014-2019)
12.3.5 Dauntless Pharmaceuticals, Inc. Recent Development
12.4 Hutchinson Medipharma Limited
12.4.1 Hutchinson Medipharma Limited Company Details
12.4.2 Company Description and Business Overview
12.4.3 Neuroendocrine Tumor Treatment Introduction
12.4.4 Hutchinson Medipharma Limited Revenue in Neuroendocrine Tumor Treatment Business (2014-2019)
12.4.5 Hutchinson Medipharma Limited Recent Development
12.5 Ispen
12.5.1 Ispen Company Details
12.5.2 Company Description and Business Overview
12.5.3 Neuroendocrine Tumor Treatment Introduction
12.5.4 Ispen Revenue in Neuroendocrine Tumor Treatment Business (2014-2019)
12.5.5 Ispen Recent Development
12.6 Novartis AG
12.6.1 Novartis AG Company Details
12.6.2 Company Description and Business Overview
12.6.3 Neuroendocrine Tumor Treatment Introduction
12.6.4 Novartis AG Revenue in Neuroendocrine Tumor Treatment Business (2014-2019)
12.6.5 Novartis AG Recent Development
12.7 Progenics Pharmaceuticals, Inc.
12.7.1 Progenics Pharmaceuticals, Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Neuroendocrine Tumor Treatment Introduction
12.7.4 Progenics Pharmaceuticals, Inc. Revenue in Neuroendocrine Tumor Treatment Business (2014-2019)
12.7.5 Progenics Pharmaceuticals, Inc. Recent Development
12.8 Tarveda Therapeutics
12.8.1 Tarveda Therapeutics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Neuroendocrine Tumor Treatment Introduction
12.8.4 Tarveda Therapeutics Revenue in Neuroendocrine Tumor Treatment Business (2014-2019)
12.8.5 Tarveda Therapeutics Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Neuroendocrine Tumor Treatment Key Market Segments
Table Key Players Neuroendocrine Tumor Treatment Covered
Table Global Neuroendocrine Tumor Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Everolimus Figures
Table Key Players of Everolimus
Figuer Sunitinib Figures
Table Key Players of Sunitinib
Figuer Lu-Dotatate Figures
Table Key Players of Lu-Dotatate
Figuer Lanreotide Figures
Table Key Players of Lanreotide
Figuer Octreotide Figures
Table Key Players of Octreotide
Table Global Neuroendocrine Tumor Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Neuroendocrine Tumor Treatment Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Clinic Case Studies
Figure Others Case Studies
Figure Neuroendocrine Tumor Treatment Report Years Considered
Figure Global Neuroendocrine Tumor Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Neuroendocrine Tumor Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Neuroendocrine Tumor Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Neuroendocrine Tumor Treatment Market Share by Regions 2014-2019
Figure Global Neuroendocrine Tumor Treatment Market Share by Regions 2014-2019
Figure Global Neuroendocrine Tumor Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Neuroendocrine Tumor Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Neuroendocrine Tumor Treatment Market Share by by Players (2014-2019)
Figure Global Neuroendocrine Tumor Treatment Market Share by by Players in 2018
Table Global Neuroendocrine Tumor Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Neuroendocrine Tumor Treatment Product/Solution/Service
Table Date of Enter into Neuroendocrine Tumor Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Neuroendocrine Tumor Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Neuroendocrine Tumor Treatment Market Size Share by Type (2014-2019)
Figure Global Neuroendocrine Tumor Treatment Market Size Market Share by Type (2014-2019)
Table Global Neuroendocrine Tumor Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Neuroendocrine Tumor Treatment Market Size Share by Application (2014-2019)
Figure Global Neuroendocrine Tumor Treatment Market Size Market Share by Application (2014-2019)
Figure Global Neuroendocrine Tumor Treatment Revenue Market Share by Application in 2018
Figure North America Neuroendocrine Tumor Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Neuroendocrine Tumor Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Neuroendocrine Tumor Treatment Market Share (2018-2019)
Table North America Neuroendocrine Tumor Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Neuroendocrine Tumor Treatment Market Share by Type 2014-2019
Table North America Neuroendocrine Tumor Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Neuroendocrine Tumor Treatment Market Share by Application 2014-2019
Figure Europe Neuroendocrine Tumor Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Neuroendocrine Tumor Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Neuroendocrine Tumor Treatment Market Share (2018-2019)
Table Europe Neuroendocrine Tumor Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Neuroendocrine Tumor Treatment Market Share by Type 2014-2019
Table Europe Neuroendocrine Tumor Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Neuroendocrine Tumor Treatment Market Share by Application 2014-2019
Figure China Neuroendocrine Tumor Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Neuroendocrine Tumor Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Neuroendocrine Tumor Treatment Market Share (2018-2019)
Table China Neuroendocrine Tumor Treatment Market Size by Type 2014-2019 (Million US$)
Table China Neuroendocrine Tumor Treatment Market Share by Type 2014-2019
Table China Neuroendocrine Tumor Treatment Market Size by Application 2014-2019 (Million US$)
Table China Neuroendocrine Tumor Treatment Market Share by Application 2014-2019
Figure Japan Neuroendocrine Tumor Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Neuroendocrine Tumor Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Neuroendocrine Tumor Treatment Market Share (2018-2019)
Table Japan Neuroendocrine Tumor Treatment Market Size by Type 2014-2019 (Million US$)
Table Japan Neuroendocrine Tumor Treatment Market Share by Type 2014-2019
Table Japan Neuroendocrine Tumor Treatment Market Size by Application 2014-2019 (Million US$)
Table Japan Neuroendocrine Tumor Treatment Market Share by Application 2014-2019
Figure Southeast Asia Neuroendocrine Tumor Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Neuroendocrine Tumor Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Neuroendocrine Tumor Treatment Market Share (2018-2019)
Table Southeast Asia Neuroendocrine Tumor Treatment Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Neuroendocrine Tumor Treatment Market Share by Type 2014-2019
Table Southeast Asia Neuroendocrine Tumor Treatment Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Neuroendocrine Tumor Treatment Market Share by Application 2014-2019
Figure India Neuroendocrine Tumor Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Neuroendocrine Tumor Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Neuroendocrine Tumor Treatment Market Share (2018-2019)
Table India Neuroendocrine Tumor Treatment Market Size by Type 2014-2019 (Million US$)
Table India Neuroendocrine Tumor Treatment Market Share by Type 2014-2019
Table India Neuroendocrine Tumor Treatment Market Size by Application 2014-2019 (Million US$)
Table India Neuroendocrine Tumor Treatment Market Share by Application 2014-2019
Figure Central & South America Neuroendocrine Tumor Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Neuroendocrine Tumor Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Neuroendocrine Tumor Treatment Market Share (2018-2019)
Table Central & South America Neuroendocrine Tumor Treatment Market Size by Type 2014-2019 (Million US$)
Table Central & South America Neuroendocrine Tumor Treatment Market Share by Type 2014-2019
Table Central & South America Neuroendocrine Tumor Treatment Market Size by Application 2014-2019 (Million US$)
Table Central & South America Neuroendocrine Tumor Treatment Market Share by Application 2014-2019
Table Exelixis, Inc. Company Details
Table Exelixis, Inc. Revenue in Neuroendocrine Tumor Treatment Business 2014-2019 (Million US$)
Figure Exelixis, Inc. Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2014-2019)
Table Exelixis, Inc. Recent Development
Table Advanced Accelerator Applications Company Details
Table Advanced Accelerator Applications Revenue in Neuroendocrine Tumor Treatment Business 2014-2019 (Million US$)
Figure Advanced Accelerator Applications Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2014-2019)
Table Advanced Accelerator Applications Recent Development
Table Dauntless Pharmaceuticals, Inc. Company Details
Table Dauntless Pharmaceuticals, Inc. Revenue in Neuroendocrine Tumor Treatment Business 2014-2019 (Million US$)
Figure Dauntless Pharmaceuticals, Inc. Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2014-2019)
Table Dauntless Pharmaceuticals, Inc. Recent Development
Table Hutchinson Medipharma Limited Company Details
Table Hutchinson Medipharma Limited Revenue in Neuroendocrine Tumor Treatment Business 2014-2019 (Million US$)
Figure Hutchinson Medipharma Limited Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2014-2019)
Table Hutchinson Medipharma Limited Recent Development
Table Ispen Company Details
Table Ispen Revenue in Neuroendocrine Tumor Treatment Business 2014-2019 (Million US$)
Figure Ispen Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2014-2019)
Table Ispen Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Neuroendocrine Tumor Treatment Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2014-2019)
Table Novartis AG Recent Development
Table Progenics Pharmaceuticals, Inc. Company Details
Table Progenics Pharmaceuticals, Inc. Revenue in Neuroendocrine Tumor Treatment Business 2014-2019 (Million US$)
Figure Progenics Pharmaceuticals, Inc. Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2014-2019)
Table Progenics Pharmaceuticals, Inc. Recent Development
Table Tarveda Therapeutics Company Details
Table Tarveda Therapeutics Revenue in Neuroendocrine Tumor Treatment Business 2014-2019 (Million US$)
Figure Tarveda Therapeutics Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2014-2019)
Table Tarveda Therapeutics Recent Development
Table Global Neuroendocrine Tumor Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Neuroendocrine Tumor Treatment Market Size Share by Regions (2019-2025)
Figure Global Neuroendocrine Tumor Treatment Market Size Share by Regions in 2025
Figure North America Neuroendocrine Tumor Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Neuroendocrine Tumor Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Neuroendocrine Tumor Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Neuroendocrine Tumor Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Neuroendocrine Tumor Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Neuroendocrine Tumor Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Neuroendocrine Tumor Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Neuroendocrine Tumor Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Neuroendocrine Tumor Treatment Market Size by Product (2019-2025)
Figure Global Neuroendocrine Tumor Treatment Market Size by Product in 2025
Table Global Neuroendocrine Tumor Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Neuroendocrine Tumor Treatment Market Size by Application (2019-2025)
Figure Global Neuroendocrine Tumor Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Exelixis, Inc.、Advanced Accelerator Applications、Dauntless Pharmaceuticals, Inc.、Hutchinson Medipharma Limited、Ispen、Novartis AG、Progenics Pharmaceuticals, Inc.、Tarveda Therapeutics

★調査レポート[神経内分泌腫瘍治療の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18748)販売に関する免責事項を必ずご確認ください。
★調査レポート[神経内分泌腫瘍治療の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 線維形成性小円形細胞腫瘍の治療の世界市場：規模・現状・予測2019-2025
    DATA909X18378 / QYResearch / 2019年11月25日 / ※当調査レポートでは、線維形成性小円形細胞腫瘍の治療の世界市場について調査・分析し、線維形成性小円形細胞腫瘍の治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（免疫療法、外科手術、化学療法、放射線療法）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の線維形成性小円形細胞腫瘍の治療市場動向 ・主要企業別マーケットシェア ・線維形成性小円形細胞腫瘍の治療の種類別市場規模2014-2019 （免疫療法、外科手術、化学療法、放射線療法） ・線維形成性小円形細胞腫瘍の治療の用途別市場規模2014-2019 （病院、診療所、その他） ・線維形成性小円形細胞腫瘍の治療の北米市場：主要企業・種類別/用途別市場規模 ・線維形成性小円形細胞腫瘍の治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Desmoplastic Small Round Cell Tumor (DSRCT) refers to a rare kind of aggressive soft tissue cancer that usually begins at abdomen and hematogenously disseminates to the liver.In 2018, the global Desmoplastic Small Round Cell Tumor Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Desmoplastic Small Round Cell Tumor Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Desmoplastic Small Round Cell Tumor Treatment development in...
  • 腫瘍高周波アブレーションの世界市場：規模・現状・予測2019-2025
    DATA909X19055 / QYResearch / 2019年11月25日 / ※当調査レポートでは、腫瘍高周波アブレーションの世界市場について調査・分析し、腫瘍高周波アブレーションの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（肺がん、腎臓がん、乳がん、前立腺がん、肝臓がん、その他）、用途別（病院、がん専門クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の腫瘍高周波アブレーション市場動向 ・主要企業別マーケットシェア ・腫瘍高周波アブレーションの種類別市場規模2014-2019 （肺がん、腎臓がん、乳がん、前立腺がん、肝臓がん、その他） ・腫瘍高周波アブレーションの用途別市場規模2014-2019 （病院、がん専門クリニック、その他） ・腫瘍高周波アブレーションの北米市場：主要企業・種類別/用途別市場規模 ・腫瘍高周波アブレーションのヨーロッパ市場：主要企業・種類別/用途別市場規模...Radiofrequency ablation (or RFA) is a procedure used to reduce pain. An electrical current produced by a radio wave is used to heat up a small area of nerve tissue, thereby decreasing pain signals from that specific area.In 2018, the global Tumor Radiofrequency Ablation market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Tumor Radiofrequency Ablation status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tumor Radiofrequency Ablation development...
  • 腫瘍特異抗原の世界市場：規模・現状・予測2019-2025
    DATA909X19057 / QYResearch / 2019年11月25日 / ※当調査レポートでは、腫瘍特異抗原の世界市場について調査・分析し、腫瘍特異抗原の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（コーディング領域、非コーディング領域）、用途別（創薬、開発、診断、臨床＆基礎研究、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の腫瘍特異抗原市場動向 ・主要企業別マーケットシェア ・腫瘍特異抗原の種類別市場規模2014-2019 （コーディング領域、非コーディング領域） ・腫瘍特異抗原の用途別市場規模2014-2019 （創薬、開発、診断、臨床＆基礎研究、その他） ・腫瘍特異抗原の北米市場：主要企業・種類別/用途別市場規模 ・腫瘍特異抗原のヨーロッパ市場：主要企業・種類別/用途別市場規模...Tumor-specific Antigen is a new Antigen that is expressed on the surface of certain Tumor cells but not on normal cells.Such antigens may be present in tumors of the same tissue type in different individuals.Tumor-specific antigens help the body develop an immune response to cancer cells.They could be used as potential targets for targeted therapy or immunotherapy to help improve the body's immune system to kill more cancer cells.Tumor-specific antigens can also be used in laboratory tests to help identify certain types of cancer.In 2018, the global Tumor-Specific Antigen market size was xx million US$ and it is expected to...
  • 腫瘍マイクロ波アブレーションシステムの世界市場：規模・現状・予測2019-2025
    DATA909X19053 / QYResearch / 2019年11月25日 / ※当調査レポートでは、腫瘍マイクロ波アブレーションシステムの世界市場について調査・分析し、腫瘍マイクロ波アブレーションシステムの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（肺がん、腎臓がん、乳がん、前立腺がん、肝臓がん、その他）、用途別（病院、がん専門クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の腫瘍マイクロ波アブレーションシステム市場動向 ・主要企業別マーケットシェア ・腫瘍マイクロ波アブレーションシステムの種類別市場規模2014-2019 （肺がん、腎臓がん、乳がん、前立腺がん、肝臓がん、その他） ・腫瘍マイクロ波アブレーションシステムの用途別市場規模2014-2019 （病院、がん専門クリニック、その他） ・腫瘍マイクロ波アブレーションシステムの北米市場：主要企業・種類別/用途別市場規模 ・腫瘍マイクロ波アブレーションシステムのヨーロッパ市場：主要企業・種類別/用途別市場規模...Microwave Ablation Systems is an emerging tissue ablation technique utilized to treat large, small tumors, and inoperable tumors. The technique uses numerous antennae to achieve microwave ablation in a small targeted area to prevent healthy tissue damage. This ablation technique is widely employed to treat various diseases such as lung, kidney, breast, and liver cancer.In 2018, the global Tumor Microwave Ablation Systems market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Tumor Microwave Ablation Systems status,...
  • 腫瘍壊死因子(TNF)阻害薬の世界市場：規模・現状・予測2019-2025
    DATA909X19054 / QYResearch / 2019年11月25日 / ※当調査レポートでは、腫瘍壊死因子(TNF)阻害薬の世界市場について調査・分析し、腫瘍壊死因子(TNF)阻害薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ヒュミラ、エンブレル、レミケード、シンポニー/シンポニーアリア、シムジア、バイオシミラー）、用途別（関節リウマチ、乾癬、乾癬性関節炎、クローン病、潰瘍性大腸炎、強直性脊椎炎、若年性特発性関節炎、化膿性汗腺炎、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の腫瘍壊死因子(TNF)阻害薬市場動向 ・主要企業別マーケットシェア ・腫瘍壊死因子(TNF)阻害薬の種類別市場規模2014-2019 （ヒュミラ、エンブレル、レミケード、シンポニー/シンポニーアリア、シムジア、バイオシミラー） ・腫瘍壊死因子(TNF)阻害薬の用途別市場規模2014-2019 （関節リウマチ、乾癬、乾癬性関節炎、クローン病、潰瘍性大腸炎、強直性脊椎炎、若年性特発性関節炎、化膿性汗腺炎、その他） ・腫瘍壊死因子(TNF)阻害薬の北米市場：主要企業・種類別/用途別市場規模 ・腫瘍壊死因子(TNF)阻害薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory response. TNF is involved in autoimmune and immune-mediated disorders such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, psoriasis, hidradenitis suppurativa and refractory asthma, so TNF inhibitors may be used in their treatment. The important side effects of TNF inhibitors include lymphomas, infections (especially reactivation of latent tuberculosis), congestive heart failure, demyelinating disease, a lupus-like syndrome, induction of auto-antibodies, injection site reactions, and systemic side effects.The market growth is expected to be driven by new product launches, promising pipeline, increasing incidence of autoimmune diseases, and a significant rise in consumer awareness regarding...
  • 腫瘍追跡システムの世界市場：規模・現状・予測2019-2025
    DATA909X19056 / QYResearch / 2019年11月25日 / ※当調査レポートでは、腫瘍追跡システムの世界市場について調査・分析し、腫瘍追跡システムの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（前立腺がん、胃がん、肺がん、肝臓がん、乳がん、その他）、用途別（がん研究所、放射線治療センター、外来手術センター）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の腫瘍追跡システム市場動向 ・主要企業別マーケットシェア ・腫瘍追跡システムの種類別市場規模2014-2019 （前立腺がん、胃がん、肺がん、肝臓がん、乳がん、その他） ・腫瘍追跡システムの用途別市場規模2014-2019 （がん研究所、放射線治療センター、外来手術センター） ・腫瘍追跡システムの北米市場：主要企業・種類別/用途別市場規模 ・腫瘍追跡システムのヨーロッパ市場：主要企業・種類別/用途別市場規模...Tumor tracking systems provide a comparatively faster and more efficient method for the evaluation and track tumor cells for the better understanding of the cancer type, mutations, and cell life cycle leading to the effective management of cancer.In 2018, the global Tumor Tracking System market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Tumor Tracking System status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tumor Tracking System...

    • ◆H&Iグローバルリサーチのお客様（例）◆